ECT Library


F E A T U R E D    A R T I C L E

Each Day I Like It Better: Autism, ECT & the Treatment of Our Most Impaired Children

October 31st, 2014
Say "shock therapy" to most people and what comes to mind? For many, it is some version of Jack Nicholson’s experience in One Flew Over the Cuckoo’s Nest: a patient writhing on the table as a crazed doctor sends waves of electricity through his brain, all with disastrous consequences. Even during my psychiatry clerkship as a ...

Depression Commonly Strikes Seniors & Other Vital Facts About Depressed Seniors

Depression Commonly Strikes Seniors & Other Vital Facts About Depressed SeniorsThere’s a common belief that depression is a normal part of aging. It’s not. But unfortunately, it is prevalent among the elderly. A 2000 study published in the Archives of General Psychiatry ...

5 Outdated Beliefs About ECT

5 Outdated Beliefs About ECTWhen severe depression doesn’t respond to antidepressants and psychotherapy, electroconvulsive therapy (ECT) may be the next step. ECT is typically prescribed for severe depression, particularly for treatment-resistant depression, a disorder that still persists after several adequate trials of ...

What You Need to Know About Treatment-Resistant Depression

What You Need to Know About Treatment-Resistant Depression Depression can be effectively treated with psychotherapy and medication. But it takes time to find the correct medication and dose. Still, for about one million patients with depression, even several trials of medication don’t seem to be enough, ...

Risks and Side Effects of ECT

Lawrence Park, AM, MD presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are his remarks describing a research literature review of the risks and primary side effects of ECT, as published in the public record of the meeting. Key risks ...

Katherine Kitty Dukakis on ECT

Katherine Kitty Dukakis presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are her remarks as published in the public record of the meeting. My name is Katherine Kitty Dukakis, and I live in Brookline, Massachusetts, except during the months ...

Research Findings on Memory and Cognitive Impairment in ECT

Dr. Peter Como presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. This presentation comes from the public record of the meeting. The FDA systematic review of the literature of cognitive adverse events [of ECT] included only randomized controlled trials ...

The Reliability of ECT Machines

This exchange occurred during the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are the remarks as published in the public record of the meeting. MS. CARRAS: I have a question for Dr. Weiner. Dr. Weiner, I did a lot ...

Informed Consent for ECT

Dr. Sarah Lisanby answered questions during the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are her answers as published in the public record of the meeting. So my name is Dr. Sarah Lisanby. I'm happy to answer your question about ...

Donald Johnson on ECT

Donald Johnson presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are his remarks as published in the public record of the meeting. I thank you for this opportunity. Forgive me my emotion. I was here at ...

Mary Rosedale on ECT

Mary Rosedale presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are her remarks as published in the public record of the meeting. My name is Mary Rosedale. I'm a board certified psychiatric nurse practitioner and an Assistant Professor ...

Dr. David Boger on ECT

Dr. David Boger presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are his remarks as published in the public record of the meeting. Good afternoon. My name is Dr. David Boger. I'm a board certified adult psychiatrist ...

Lauren Tenney on ECT

Lauren Tenney presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are her remarks as published in the public record of the meeting. Hi, thanks. My name is Lauren Tenney. I'm a survivor of psychiatry. I was ...

Carol Jean Reynolds on ECT

Carol Jean Reynolds presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are her remarks as published in the public record of the meeting. Thank you for permitting me as well as other members of the public to provide comments ...

Dr. Daniel Fisher on ECT

Dr. Daniel Fisher presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are his remarks as published in the public record of the meeting. I represent a national mental health consumer organization, to answer an earlier question, the National Coalition ...

Dorothy Dundas on ECT

Dorothy Dundas presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are her remarks as published in the public record of the meeting. My name is Dorothy Dundas, and I am 69 years old from Newton, Massachusetts, and I've been ...

Evelyn Scogin on ECT

Evelyn Scogin presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are her remarks as published in the public record of the meeting. My name is Evelyn Scogin. I'm here to tell you my story of assault from ECT ...

Amy Lutz on ECT

Amy Lutz presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are her remarks as published in the public record of the meeting. Thank you, members of the Panel. My name is Amy Lutz, and my son, Jonah, suffers ...

Anita Hagin on ECT

Psychiatric nurse Anita Hagin presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are her remarks as published in the public record of the meeting. Thank you for this opportunity to speak to the Panel. I'm a psychiatric nurse at ...

Dr. John Breeding on ECT

Dr. John Breeding presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are his remarks as published in the public record of the meeting. My name is John Breeding. I've been a Texas psychologist for almost 30 years, and ...

Julie Hersh on ECT

Julie Hersh presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are her remarks as published in the public record of the meeting. Hi. I'm Julie Hersh, and I am an ECT patient, and I'm part of the silent ...

Dr. William Narrow on ECT

Dr. William Narrow presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are his remarks as published in the public record of the meeting. My name is William Narrow. I've been a board certified psychiatrist for 20 years and ...

Dr. Robert Roca on ECT

Dr. Robert Roca presented to the U.S. Food and Drug Administration Neurological Devices Panel examining the reclassification of electroconvulsive therapy (ECT) devices on January 27, 2011. These are his remarks as published in the public record of the meeting. Thank you for this opportunity to speak. I'm Dr. Robert Roca. I've no ...
 
 
Subscribe to Our Weekly Newsletter


Find a Therapist
Enter ZIP or postal code



Users Online: 7657
Join Us Now!